Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phillip G Febbo

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
Future Oncology (London, England)|March 25, 2006
Epidermal growth factor receptor mutations predict sensitivity to gefitinib in patients with non-small-cell lung cancerRichard F Riedel, Phillip G Febbo
Autophagy|December 23, 2009
MYC activity mitigates response to rapamycin in prostate cancer through 4EBP1-mediated inhibition of autophagyBala S Balakumaran, J Taylor Herbert, Phillip G Febbo
Clinical & Experimental Metastasis|June 5, 2008
Dunning rat prostate adenocarcinomas and alternative splicing reporters: powerful tools to study epithelial plasticity in prostate tumors in vivoSebastian Oltean, Phillip G Febbo, Mariano A Garcia-Blanco
Reviews in Urology|February 24, 2018
Active Surveillance Use Among a Low-risk Prostate Cancer Population in a Large US Payer System: 17-Gene Genomic Prostate Score Versus Other Risk Stratification MethodsSteven Canfield, Michael J Kemeter, John Hornberger, et al.
Reviews in Urology|October 6, 2018
Balancing Confounding and Generalizability Using Observational, Real-world Data: 17-gene Genomic Prostate Score Assay Effect on Active SurveillanceSteven Canfield, Michael J Kemeter, Phillip G Febbo, et al.
The American Journal of Pathology|August 19, 2007
Stromally expressed c-Jun regulates proliferation of prostate epithelial cellsWenhua Li, Chin-Lee Wu, Phillip G Febbo, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 7, 2012
Predictive biomarkers in advance of a companion drug: ahead of their time?Robin K Kelley, Chloe Atreya, Alan P Venook, et al.
Plos Computational Biology|February 20, 2008
Modeling cancer progression via pathway dependenciesElena J Edelman, Justin Guinney, Jen-Tsan Chi, et al.
Cancer Research|June 17, 2005
Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumorsJames V Alvarez, Phillip G Febbo, Sridhar Ramaswamy, et al.
The Journal of Urology|April 12, 2005
Androgen mediated regulation and functional implications of fkbp51 expression in prostate cancerPhillip G Febbo, Mark Lowenberg, Aaron R Thorner, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Future Oncology (London, England)|March 25, 2006
Epidermal growth factor receptor mutations predict sensitivity to gefitinib in patients with non-small-cell lung cancerRichard F Riedel, Phillip G Febbo
Autophagy|December 23, 2009
MYC activity mitigates response to rapamycin in prostate cancer through 4EBP1-mediated inhibition of autophagyBala S Balakumaran, J Taylor Herbert, Phillip G Febbo
Clinical & Experimental Metastasis|June 5, 2008
Dunning rat prostate adenocarcinomas and alternative splicing reporters: powerful tools to study epithelial plasticity in prostate tumors in vivoSebastian Oltean, Phillip G Febbo, Mariano A Garcia-Blanco
Reviews in Urology|February 24, 2018
Active Surveillance Use Among a Low-risk Prostate Cancer Population in a Large US Payer System: 17-Gene Genomic Prostate Score Versus Other Risk Stratification MethodsSteven Canfield, Michael J Kemeter, John Hornberger, et al.
Reviews in Urology|October 6, 2018
Balancing Confounding and Generalizability Using Observational, Real-world Data: 17-gene Genomic Prostate Score Assay Effect on Active SurveillanceSteven Canfield, Michael J Kemeter, Phillip G Febbo, et al.
The American Journal of Pathology|August 19, 2007
Stromally expressed c-Jun regulates proliferation of prostate epithelial cellsWenhua Li, Chin-Lee Wu, Phillip G Febbo, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 7, 2012
Predictive biomarkers in advance of a companion drug: ahead of their time?Robin K Kelley, Chloe Atreya, Alan P Venook, et al.
Plos Computational Biology|February 20, 2008
Modeling cancer progression via pathway dependenciesElena J Edelman, Justin Guinney, Jen-Tsan Chi, et al.
Cancer Research|June 17, 2005
Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumorsJames V Alvarez, Phillip G Febbo, Sridhar Ramaswamy, et al.
The Journal of Urology|April 12, 2005
Androgen mediated regulation and functional implications of fkbp51 expression in prostate cancerPhillip G Febbo, Mark Lowenberg, Aaron R Thorner, et al.
Pageof 8